Improved Quality of Life with Watch-and-Wait After Rectal Cancer Treatment

Personalized total neoadjuvant therapy for rectal cancer enhances patient quality of life and reduces bowel dysfunction compared to standard care.

Watch-and-wait patients reported significantly lower rates of lower anterior resection syndrome (55.6% vs. 87.5%, p = 0.012) and major symptoms (29.6% vs. 58.3%, p = 0.039).
Quality of life scores improved, notably in stool frequency (20.7 vs. 30.8, p = 0.009) and abdominal pain (5.8 vs. 14.1, p = 0.005).

Surgeons should consider personalized watch-and-wait protocols for eligible patients to improve post-treatment outcomes and satisfaction.

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Intestine and Lower Gastrointestinal Tract.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

More in Intestine and Lower Gastrointestinal Tract

Ann Surg Oncol2 Nov 2026

Patients smoking at diagnosis were less likely to have a favorable response to treatment before rectal cancer surgery; former smokers were not.

JAMA Surg30 Oct 2026

For severe slow-transit constipation, removing less colon gave similar symptom relief at one year, with less early incontinence.

Surg Endosc29 Oct 2026

In low rectal cancer surgery, removing the specimen through the anus was linked to fewer wound complications and less pain in the first two days.